Showing results (1201-1210 of 1,708) with videos related to
Sort By:
Pageof 171
European Heart Journal|May 25, 2026
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndromeJohan Wouter Jukema, Nicolaas J Van Neer, Michael Szarek, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 21, 2016
Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stentsKumaran Kolandaivelu, Lynn Bailey, Stefano Buzzi, et al.Clinical Cardiology|March 16, 2017
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention TrialDeepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, et al.ESC Heart Failure|September 15, 2025
Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58Paul M Haller, Stephen D Wiviott, David D Berg, et al.JACC. Heart Failure|August 29, 2024
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 InhibitorsRushin Patel, Mark Wadid, Bhargav Makwana, et al.Journal of the American Heart Association|June 18, 2015
Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary interventionTanush Gupta, Neha Paul, Dhaval Kolte, et al.Journal of the American Heart Association|May 16, 2020
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 TrialRemo H M Furtado, Ramkumar V Venkateswaran, Jose C Nicolau, et al.Circulation|August 29, 2015
Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality MeasuresLarry A Allen, Gregg C Fonarow, Li Liang, et al.JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Circulation|December 28, 2018
Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke HospitalsBijoy K Menon, Haolin Xu, Margueritte Cox, et al.Pageof 171